Pergolide and selegiline for Parkinson's disease.
D000818:Animals; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage; D009410:Nerve Degeneration / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy*; D010479:Pergolide / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D010627:Phenethylamines / Q000627:therapeutic use*; D012642:Selegiline / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*
D010627:Phenethylamines; D010479:Pergolide; D012642:Selegiline; D007980:Levodopa